Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

(2012) Florian M P Meier et al.   ANNALS OF THE RHEUMATIC DISEASES

Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis

(2012) P. A. Merkel et al.   ARTHRITIS AND RHEUMATISM

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

(2010) R. T. Domsic et al.   ANNALS OF THE RHEUMATIC DISEASES

Evidence-based management of rapidly progressing systemic sclerosis

(2010) Dinesh Khanna et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database

(2010) J. AVOUAC et al.   JOURNAL OF RHEUMATOLOGY

Registries in systemic sclerosis: a worldwide experience

(2010) F. Galluccio et al.   RHEUMATOLOGY

Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double-blind, randomized controlled trials

(2009) Sogol Amjadi et al.   ARTHRITIS AND RHEUMATISM

Rapamycin versus methotrexate in early diffuse systemic sclerosis: Results from a randomized, single-blind pilot study

(2009) Tien-I Karleen Su et al.   ARTHRITIS AND RHEUMATISM

Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double-blind, placebo-controlled trial

(2009) Dinesh Khanna et al.   ARTHRITIS AND RHEUMATISM

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY